Clinical Trial Update: Phase III Trial in Acute Promyelocytic Leukemia Patients [Phase 3]

View source ↗

Summary

Phase III clinical trial in acute promyelocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Leukemia | Phase 3 | Status: COMPLETED